BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 7, 2008
View Archived Issues
PRX-03140 improves ADAS-Cog scores in Alzheimer's disease patients
Read More
Abbott's A-887755 under development for passive immunotherapy in Alzheimer's disease
Read More
BMS-708163, a novel gamma-secretase inhibitor, has good pharmacological profile in animals, humans
Read More
Bristol-Myers Squibb describes creation of intranasal CGRP antagonist for migraine
Read More
Genzyme reviews quarterly highlights
Read More
The Medicines Company acquires Curacyte Discovery
Read More
InteKrin completes first close of series C venture financing for USD 18.25 million
Read More
Roche profiles H1 developments
Read More
AGS-004 immunogenic in HIV patients treated with antiretroviral therapy
Read More
Pfizer reports identification of a new series of noradrenaline reuptake inhibitors
Read More
PET probe developed for imaging of immune disorders
Read More
Ariad initiates phase II clinical trial of deforolimus in advanced endometrial cancer
Read More
Cara reports positive results from phase Ia clinical trial of CR-845 for acute and chronic pain
Read More
Tolerx initiates phase III DEFEND clinical trial of otelixizumab in type 1 diabetes
Read More
Novel agents for treatment of pain, migraine, etc., patented
Read More
Inhibitex completes phase I clinical trial and initiates multiple ascending dose trial of FV-100
Read More
Achillion receives private placement financing of approximately USD 41.5 million
Read More
Recent patents reveal discovery of compounds for Alzheimer's, Parkinson's, etc.
Read More
Discovery to submit complete response to Surfaxin approvable letter by September 2008
Read More
Novel antiinfective agents disclosed in recent patents
Read More
NIAID commits USD 7.5 million of continued funding to Alnylam to develop RNAi antiviral
Read More
Biovest joins Joint U.S.-Norway Cancer Research Program
Read More
Alnylam eyes IND filing for ALN-VSP
Read More
